Latest twist in "aspirin for primary prevention" story (rec: don't do it) hits home. nytimes.com/2021/10/12/hea… When I was in med school, I told my dad (age 52) to take an ASA daily. He was a stressed-out guy, heart attacks were common, & early evidence on ASA was supportive.(1/8)🧵
A few months later, I got a call that he had passed out on the train. The cause: a huge upper GI bleed. I felt terrible – I was pretty sure that my aspirin had caused his bleed. This was, in essence, my first prescription, and I'd nearly killed my father. I rushed home. (2/8)
The GI doc let me watch as he performed dad's endoscopy, expecting to find stomach inflammation or an ulcer. I heard the doc gasp when he found a large polyp at the stomach-esophagus junction – it was clearly not what he expected to see. Turns out it was a stomach cancer. (3/8)
Stomach cancer is usually deadly, in part because it grows stealthily for months, usually spreading before it causes symptoms. This one bled early – almost certainly due to my little aspirin. Dad had an 8-hour surgery to remove half his stomach and part of his esophagus. (4/8)
Despite the serendipitous early diagnosis, the cancer had already spread to a lymph node. His life expectancy was a year or two; the chance of cure was probably around 10%. He retired from work and got his affairs in order. (5/8)
As it happened, he was one of the lucky ones – he turned 91 this year (that's him at his grandson's wedding a few years back; sadly he's bed-bound now and nearing the end). (6/8)
It's now clear that when used for primary prevention (in pt who hasn't yet had heart disease or a stroke), the risks of aspirin outweigh benefits – it shouldn't be used this way. But if dad hadn't been on that aspirin, he likely would have died of his cancer 40 years ago. (7/8)
Moral of the story: who knows? Mostly humility – medicine is such a funny, unpredictable business. And clinical trials – which give us crucial answers to how to manage groups of patients – sometimes obscure individual stories. And sometimes it's better to be lucky than good.(8/8)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Covid (@UCSF) Chronicles,Day 521
I can't resist one more thread on boosters. I see lots of debate on data: about antibody levels, infections vs severe infctns, etc. I don't see much about the big issue: the tension between 2 perspectives – that of individuals vs. society.(1/25🧵)
It's particularly tricky when talking about a global pandemic since (as we've learned, painfully) no person is an island: individual behavior impacts the collective & vice versa. In pandemics, there's also the matter of who comprises the collective: just domestic or global?(2/25)
For those who don't follow healthcare closely, you've stumbled into a longstanding tension in health policy, one that maps pretty well to two different and (mostly) fraternal fields: clinical medicine and public health.
As a physician (though one with public health... (3/25)
Lots of criticism of new booster plans, much of it re: how much of ⬇efficacy # s are due to confounding vs truly ⬇effectiveness. To me, it seems incontrovertible that vax effectiveness is ⬇significantly, though amount of drop – particularly vs severe cases – is unclear.(1/7🧵)
I'm in support of the new booster plans. This is anecdotal, but in past week I've heard of 2 fully vaxxed people in 70s who died of Covid. With Delta & waning vax effectiveness, this will happen. Even if failure to wear masks contributed to the cases, that'll happen too. (2/7)
We can make two types of errors here: acting too early and acting too late. Given that it'll take 4-6 months to roll out boosters to 200M people, I think we need to skate to where the puck is going. To my reading, the evidence we have regarding waning vax effectiveness... (3/7)
To me, the most confusing time in the pandemic was May 2020, as we exited lockdown and nobody quite knew what they should & shouldn’t do (clean the mail? touch the dog?).
But now is giving May 2020 a run for its money. (🧵1/25)
Today, a smorgasbord of some of the most confusing issues: Delta, masking, vaccine efficacy, vax mandates, boosters.
Bottom line is that my thinking has changed. Six months ago, I felt like I understood all of the key variables when it came to the virus & vaccines. And… (2/25)
…when I learned that a variable had changed w/ Delta, I assumed nothing else had.
But now I see that it’s best to assume that nearly every parameter is different – usually for the worse. That creates cognitive vertigo, but it matches the facts on the ground. (see below.)(3/25)
My overall view: we knew much of what's in here, but there's some new information & analysis. In some cases it's brand new, in others it clarified something we knew before. In virtually all cases, the new stuff's a bit worse than I expected. Here are the key findings: (2/13)
1) Delta is much more infectious than the original: they estimate an Ro of 5-9, vs. the 2-3 for the original, which makes Delta "as transmissible as chicken pox." We've been estimating Ro of ~6 for Delta, or ~2x as infectious as original. It may be a bit worse than that.(3/13)
When I began my tweets 494d ago, it was before we had reliable local, US, or world data. So I focused on data from @UCSFHospitals. Today, we’re awash in data, yet I find my hospital's data still provides a unique lens into our situation. (1/20)
So today, a few data points from @UCSF, with my interpretation. They reinforce the case that the combo of Delta & relaxed behavior is leading to a powerful & worrisome upsurge that requires a change in approach. I knew things were bad, but it’s even worse than I thought. (2/20)
What’s particularly noteworthy about @UCSF experience is that it’s in a city w/ the nation’s highest vax rate. And cases are rising fast in our employees, of whom 93% are vaxxed. (Special thanks to Ralph Gonzales, Bob Kosnik & @SaraMurrayMD for some of the data.) Here goes:(3/20)
If you're wondering how bad Delta really is, even in highly vaccinated SF (76% of >age 12 fully vaxxed) & still w/ a lot of masking (most folks in stores), we're seeing a pretty steep Covid uptick. Daily cases up 4-fold (10->42; Fig L), hospital pts doubled (9->19; R)(Thread 1/4)
Uptick mirrored @UCSFHospitals: Covid inpatients (we were at ~3 pts two-wks ago) now 13 (Fig L). Overall test positivity rate was well below 1%; it's now up to 2.6% (Fig R). Even more worrisome, test positivity rate in asymptomatic pts was ~0.15%, now up 6-fold to 0.9%. (2/4)
I don't have vaccinated/unvaxxed breakdown for SF & UCSF – I assume most severe cases are in unvaxxed. But even for vaxxed, w/ more Covid in air expect more breakthru cases. As for me, I'm back to double-mask in stores. Still indoor dining but might abort if trends continue.(3/4)